Vitamins, supplements and COVID-19: a review of currently available evidence
The purpose of this review was to analyse clinical trials regarding vitamins and supplements for the treatment of COVID-19 infections.
Back to homepage
Tag "SARS-CoV-2"
Response to ‘Presentation and pathophysiology of neuro-COVID’
Letter to the Editor in response to Finsterer J, Scorza FA, Scorza CA. Presentation and pathophysiology of neuro-COVID. Drugs Context. 2021;10:2021-6-5
Presentation and pathophysiology of neuro-COVID
Letter to the Editor commenting on Orsucci D, Caldarazzo Ienco E, Nocita G, Napolitano A, Vista M. Neurological features of COVID-19 and their treatment: a review. Drugs Context. 2020;9:2020-5-1.
The race to a COVID-19 vaccine: opportunities and challenges in development and distribution
This article discusses the unprecedented toll of COVID-19 and how it jumpstarted the race towards potential COVID-19 vaccinations, which have been developed in less than a year. It discusses how this feat was accomplished, and how clinical development, manufacturing scale-up and distribution are occurring in parallel for the four COVID-19 vaccine front-runners. It also discusses the many challenges that still lie ahead.
Current treatment in COVID-19 disease: a rapid review
This review aims to assess the efficacy and safety of available therapies for COVID-19 in light of current evidence. These treatment options are compared based on their impact on symptom management, inpatient length of stay, and overall morbidity and mortality.
